Nomograms and instruments for the initial prostate evaluation: The ability to estimate the likelihood of identifying prostate cancer

Seminars in Urologic Oncology

Volumn 20, Issue 2, 2002, Pages 116-122

  Ohori, Makoto ^a   Swindle, Peter ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Nomogram; Prostate cancer; Systematic biopsy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTIFICIAL NEURAL NETWORK; CANCER SCREENING; CLINICAL FEATURE; HUMAN; HUMAN TISSUE; INSTRUMENT; MALE; NOMOGRAM; PATHOLOGY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REVIEW; RISK ASSESSMENT; RISK FACTOR; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0036092237     PISSN: 10810943     EISSN: None     Source Type: Journal    
DOI: 10.1053/suro.2002.32520     Document Type: Review

References (37)

1. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men
2. Cancer statistics, 2001
3. Population-based prostate cancer trends in the United States: Patterns of change in the era of prostate-specific antigen
4. Rising PSA after local therapy failure: Immediate vs deferred treatment
5. Prostate-specific antigen: Current status
6. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
7. An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: Results on 4298 cases
8. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: A prospective multicenter clinical trial
9. Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system
10. Age-specific reference ranges for serum prostate-specific antigen
11. Prostate specific antigen density: A means of distinguishing benign prostatic hypertrophy and prostate cancer
12. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
13. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer
14. Evaluation of prostasure index in the detection of prostate cancer: A preliminary report
15. Performance of a neural network in detecting prostate cancer in the prostate-specific antigen reflex range of 2.5 to 4.0 ng/mL
16. Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL
17. Artificial neural networks in the diagnosis and prognosis of prostate cancer: A pilot study
18. Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer
19. Prostate-specific antigen levels in 1695 men without evidence of prostate cancer. Findings of the American Cancer Society National Prostate Cancer Detection Project
20. Optimal predictors of prostate cancer on repeat prostate biopsy: A prospective study of 1,051 men
21. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies
22. The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancer
23. Analysis of repeated biopsy results within 1 year after a noncancer diagnosis
24. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy
25. Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: Data on men with more than one follow-up biopsy
26. Prostatic intra-epithelial neoplasia and early invasion in prostate cancer
27. The pathological interpretation and significance of prostate needle biopsy findings: Implications and current controversies
28. Follow-up of atypical prostate needle biopsies suspicious for cancer
29. Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: Clinical significance in 33 cases
30. Is repeat prostate biopsy for high-grade prostatic intraepithelial neoplasia necessary after routine 12-core sampling?
31. Early detection of prostate cancer
32. The Gordon Wilson Lecture. Natural history and treatment of early stage prostate cancer
33. The pathological features and prognosis of prostate cancer detectable with current diagnostic tests
34. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer
35. Distinguishing clinically important from unimportant prostate cancers before treatment: Value of systematic biopsies
36. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: Lack of prediction of tumor significance for men with nonpalpable prostate cancer
37. Identification of indolent (small volume, well-moderately differentiated and organ confined) prostate cancer before treatment from clinical features and systematic biopsy results